Gastroschisis Outcomes of Delivery (GOOD) Study
Eligible age
18+ yrs
Accepts
Women
Locations
25 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The objective of this study is to investigate the hypothesis that delivery at 35 0/7- 35 6/7 weeks in stable patients with gastroschisis is superior to observation and expectant management with a goal of delivery at 38 0/7 - 38 6/7 weeks. To test this hypothesis, we will complete a randomized, prospective, multi-institutional trial across NAFTNet-affiliated institutions. Patients may be enrolled in the study any time prior to 33 weeks, but will be randomized at 33 weeks to delivery at 35 weeks or observation with a goal of 38 weeks. The primary composite outcome will include stillbirth, neonatal death prior to discharge, respiratory morbidity, and need for parenteral nutrition at 30 days.
Sponsor: Medical College of Wisconsin
You may qualify if…
- ✓ To be eligible for study inclusion, subjects are required to meet the following criteria:
- ✓ 1. Speak English or Spanish
- ✓ 2. Age of ≥18 years old
- ✓ 3. Have a diagnosis of an isolated fetal gastroschisis confirmed via sonogram at ≤33 weeks gestation
- ✓ 4. Have a singleton pregnancy
- ✓ 5. Capable of providing written informed consent for study participation
- ✓ 6. Established Estimated Date of Confinement (EDC) prior to 22 0/7 weeks GA by last menstrual period (LMP) with ultrasound confirmation or ultrasound dating when LMP is unknown.
You may not qualify if…
- ✕ Subjects will be excluded from enrollment for any of the following criteria
- ✕ 1. Fetal anomaly unrelated to gastroschisis, such as a chromosomal abnormality or another congenital structural abnormality (if known; no additional testing required for research participation)
- ✕ 2. Severe intrauterine growth restriction / fetal growth restriction (defined as growth below the 5th percentile for gestational age)
- ✕ 3. Maternal history of previous stillbirth (intrauterine fetal demise)
- ✕ 4. Maternal history of spontaneous preterm (\<36 weeks) delivery
- ✕ 5. Maternal cervical length \< 25 mm prior to 24 weeks of gestation if documented
- ✕ 6. Maternal hypertension
- ✕ 7. Maternal insulin-dependent diabetes
Where it's recruiting
Phoenix
Loma Linda · Stanford
Aurora
Hartford
Wilmington
Tampa
Atlanta
Chicago · Peoria
Indianapolis
Lousiville
Baltimore
Boston
Source: ClinicalTrials.gov · NCT02774746 · last updated 2026-05-27